Related Experiment Video

Updated: Jun 6, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Antiplatelet therapy in older adults with non-ST-segment elevation acute coronary syndrome: considering risks and

Renato D Lopes1, Karen P Alexander

  • 1Duke University Medical Center, 2400 Pratt Street, Terrace Level, Durham, NC 27705, USA. renato.lopes@duke.edu

The American Journal of Cardiology
|August 22, 2009
PubMed

Insights

Older adults with non-ST-segment elevation acute coronary syndromes (NSTE ACS) may benefit most from antiplatelet agents, but face higher bleeding risks. This review examines evidence for antiplatelet use in this population.

Area of Science:

  • Cardiovascular Medicine
  • Geriatric Cardiology
  • Pharmacology

Background:

  • Antiplatelet agents are crucial for treating non-ST-segment elevation acute coronary syndromes (NSTE ACS).
  • Older adults (≥75 years) represent a high-risk group for NSTE ACS, potentially experiencing the greatest treatment benefits.
  • This demographic also faces an elevated risk of bleeding complications from these therapies.

Purpose of the Study:

  • To review existing trial evidence on antiplatelet therapy in NSTE ACS, focusing on older adults.
  • To analyze the risks and benefits of antiplatelet agents (aspirin, P2Y12 inhibitors, glycoprotein IIb/IIIa inhibitors) in the elderly.
  • To consider factors like dosage, concurrent medications, and treatment duration in this population.

Main Methods:

  • Systematic review of randomized controlled trial evidence.
  • Analysis of antiplatelet therapy efficacy and safety stratified by age.
  • Consideration of clinical practice guidelines and real-world data applicability.

Main Results:

  • Limited data from randomized trials exist for older adults in NSTE ACS.
  • Older individuals exhibit a higher propensity for bleeding complications with antiplatelet therapy.
  • Potential benefits of primary and secondary cardiovascular prevention strategies are significant in this age group.

Conclusions:

  • Guideline recommendations for antiplatelet therapy in NSTE ACS should be applied to older adults.
  • The complexity of NSTE ACS treatment in the elderly necessitates careful consideration of existing and novel therapies.
  • Further evaluation of antiplatelet strategies in real-world settings is crucial for optimizing care in older patients.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...